Mega Lifesciences PCL (BKK: MEGA)

Mega Lifesciences PCL Statistics

Total Valuation

Mega Lifesciences PCL has a market cap or net worth of THB 30.73 billion. The enterprise value is 28.20 billion.

Market Cap	30.73B
Enterprise Value	28.20B

Important Dates

The last earnings date was Tuesday, November 12, 2024.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

Mega Lifesciences PCL has 871.87 million shares outstanding. The number of shares has decreased by -0.01% in one year.

Current Share Class	n/a
Shares Outstanding	871.87M
Shares Change (YoY)	-0.01%
Shares Change (QoQ)	-1.45%
Owned by Insiders (%)	60.51%
Owned by Institutions (%)	12.21%
Float	347.14M

Valuation Ratios

The trailing PE ratio is 16.66 and the forward PE ratio is 12.31.

PE Ratio	16.66
Forward PE	12.31
PS Ratio	1.94
PB Ratio	3.33
P/TBV Ratio	n/a
P/FCF Ratio	18.05
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.69, with an EV/FCF ratio of 16.56.

EV / Earnings	15.27
EV / Sales	1.78
EV / EBITDA	7.69
EV / EBIT	8.46
EV / FCF	16.56

Financial Position

The company has a current ratio of 2.46, with a Debt / Equity ratio of 0.04.

Current Ratio	2.46
Quick Ratio	1.59
Debt / Equity	0.04
Debt / EBITDA	0.10
Debt / FCF	0.22
Interest Coverage	113.11

Financial Efficiency

Return on equity (ROE) is 20.29% and return on invested capital (ROIC) is 22.12%.

Return on Equity (ROE)	20.29%
Return on Assets (ROA)	14.73%
Return on Capital (ROIC)	22.12%
Revenue Per Employee	17.65M
Profits Per Employee	2.05M
Employee Count	900
Asset Turnover	1.12
Inventory Turnover	2.31

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.07% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-16.07%
50-Day Moving Average	38.75
200-Day Moving Average	39.28
Relative Strength Index (RSI)	30.28
Average Volume (20 Days)	658,401

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Mega Lifesciences PCL had revenue of THB 15.88 billion and earned 1.85 billion in profits. Earnings per share was 2.12.

Revenue	15.88B
Gross Profit	7.74B
Operating Income	3.33B
Pretax Income	2.14B
Net Income	1.85B
EBITDA	3.59B
EBIT	3.33B
Earnings Per Share (EPS)	2.12

Balance Sheet

The company has 2.92 billion in cash and 378.02 million in debt, giving a net cash position of 2.54 billion or 2.91 per share.

Cash & Cash Equivalents	2.92B
Total Debt	378.02M
Net Cash	2.54B
Net Cash Per Share	2.91
Equity (Book Value)	9.24B
Book Value Per Share	10.60
Working Capital	5.69B

Cash Flow

In the last 12 months, operating cash flow was 1.97 billion and capital expenditures -263.90 million, giving a free cash flow of 1.70 billion.

Operating Cash Flow	1.97B
Capital Expenditures	-263.90M
Free Cash Flow	1.70B
FCF Per Share	1.95

Margins

Gross margin is 48.74%, with operating and profit margins of 20.98% and 11.62%.

Gross Margin	48.74%
Operating Margin	20.98%
Pretax Margin	13.48%
Profit Margin	11.62%
EBITDA Margin	22.63%
EBIT Margin	20.98%
FCF Margin	10.72%

Dividends & Yields

This stock pays an annual dividend of 1.60, which amounts to a dividend yield of 4.54%.

Dividend Per Share	1.60
Dividend Yield	4.54%
Dividend Growth (YoY)	-3.03%
Years of Dividend Growth	4
Payout Ratio	75.60%
Buyback Yield	0.01%
Shareholder Yield	4.55%
Earnings Yield	6.00%
FCF Yield	5.54%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Mega Lifesciences PCL has an Altman Z-Score of 8.14.

Altman Z-Score	8.14
Piotroski F-Score	n/a